| CTRI Number |
CTRI/2025/08/092730 [Registered on: 11/08/2025] Trial Registered Prospectively |
| Last Modified On: |
10/08/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A study comparing two anesthesia methods (Thoracic Segmental Spinal Anesthesia and Erector Spinae Plane Block) for pain relief after breast cancer surgery (modified radical mastectomy) |
|
Scientific Title of Study
|
Comparative study of Thoracic Segmental
Spinal Anesthesia and Erector Spinae Plane Block for modified radical mastectomy: A randomized controlled clinical trial
|
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Nunna Mounika |
| Designation |
PG Resident |
| Affiliation |
Institute of medical sciences and sum hospital, Siksha O anusandhan |
| Address |
Department of Anesthesiology, Modular OT 3 complex, first floor, institute of medical sciences and sum hospital, Siksha o Anusandhan, Khordha, Odisha, India, 751003
Khordha ORISSA 751003 India |
| Phone |
7702386784 |
| Fax |
|
| Email |
mounikanunna01@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Bhavna Sriramka |
| Designation |
Professor |
| Affiliation |
Department of Anesthesiology, Modular OT 3 complex, first floor, institute of medical sciences and sum hospital, Siksha o Anusandhan, Khordha, Odisha, India, 751003 Institute of medical sciences and sum hospital, Siksha O anusandhan Khordha ORISSA 751003 |
| Address |
Department of Anesthesiology, Modular OT 3 complex, first floor, institute of medical sciences and sum hospital, Siksha o Anusandhan, Khordha, Odisha, India, 751003 Institute of medical sciences and sum hospital, Siksha O anusandhan Khordha ORISSA 751003 India |
| Phone |
94060333609 |
| Fax |
|
| Email |
bhavna.sriramka@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Bhavna Sriramka |
| Designation |
Professor |
| Affiliation |
Department of Anesthesiology, Modular OT 3 complex, first floor, institute of medical sciences and sum hospital, Siksha o Anusandhan, Khordha, Odisha, India, 751003 Institute of medical sciences and sum hospital, Siksha O anusandhan Khordha ORISSA 751003 |
| Address |
Department of Anesthesiology, Modular OT 3 complex, first floor, institute of medical sciences and sum hospital, Siksha o Anusandhan, Khordha, Odisha, India, 751003 Institute of medical sciences and sum hospital, Siksha O anusandhan Khordha ORISSA 751003 India |
| Phone |
94060333609 |
| Fax |
|
| Email |
bhavna.sriramka@gmail.com |
|
|
Source of Monetary or Material Support
|
| IMS and SUM Hospital, Siksha O Anusandhan university, K8,Kalinga Nagar, Bhubaneswar, Odisha, India
Pin Code - 751003 |
|
|
Primary Sponsor
|
| Name |
Institute of medical sciences and sum hospital |
| Address |
K8, Kalinga nagar, Bhubaneswar, Odisha, PIN: 751003 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DrNunna Mounika |
Institute of medical sciences and sum hospital, Siksha O anusandhan |
Department of Anesthesiology, Modular OT 3 Complex, First Floor, Institute of Medical Sciences and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), K8, Kalinganagar, Bhubaneswar, Khordha, Odisha, India, PIN 751003 Khordha ORISSA |
7702386784
mounikanunna01@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee, Ims and Sum Hospital, BHubaneswar |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Erector Spinae Plane Block (ESPB) |
: Patients receive ESPB at T5 under ultrasound guidance with 20 ml of 0.2% ropivacaine plus 0.5 mcg/kg dexmedetomidine injected on the surgical side. |
| Intervention |
Thoracic Segmental Spinal Anesthesia (TSSA) |
Patients receive TSSA at T4–T5 interspace with 1.5 ml of 0.2% isobaric ropivacaine plus 5 mcg dexmedetomidine. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Female |
| Details |
1. Patients willing to participate with written informed consent.
2. ASA grade I and II.
3. Patients age more than 18 years.
4. Patients undergoing modified radical mastectomy.
|
|
| ExclusionCriteria |
| Details |
1. ASA grade more than II.
2. Thrombocytopenia or coagulopathy.
3. Local site infection.
4. Spinal or chest deformity.
5. Surgery duration expected to exceed 3 hours.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Comparison of postoperative pain scores (VAS) between Group TSSA and Group ESPB. |
after 30 minutes and 2 hours post extubation |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Incidence of adverse events (hypotension, bradycardia, nausea, vomiting, block-related complications). |
at 12 hours post operatively & at 24 hours postoperatively |
|
|
Target Sample Size
|
Total Sample Size="90" Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
26/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This prospective randomized controlled trial compares thoracic segmental spinal anesthesia (TSSA) with erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing modified radical mastectomy. Ninety ASA I and II patients aged above 18 years will be randomized into two groups: Group TSSA receiving 1.5 ml of 0.2% isobaric ropivacaine with 5 mcg dexmedetomidine at T4–T5 interspace, and Group ESPB receiving 20 ml of 0.2% ropivacaine with 0.5 mcg/kg dexmedetomidine at T5 level under ultrasound guidance. Primary outcome is postoperative pain scores measured by VAS at 30 minutes and 2 hours. Secondary outcomes include time to first analgesia, rescue analgesic requirements, and incidence of complications. Randomization uses computer-generated numbers with sealed opaque envelope concealment; outcome assessor will be blinded. Statistical analysis includes Mann-Whitney U test, unpaired t-test, and Chi-square test. The study aims to evaluate which regional technique provides superior postoperative analgesia in breast cancer surgeries.
|